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Abstract: Background: the aim of the study is to define the role of SPET/CT in radio-guided sentinel lymph node surgery 
identification in cutaneous Malignant Melanoma (MM) and to assess if SPET/CT data can modify surgery time. 
Materials and Methods: 96 patients with MM (58 men and 38 women, mean age of 44 years, range 14-71 years) were 
divided into two groups. 66 patients (group I) were submitted to sentinel node (SN) research by planar 
lymphoscintigraphy; 30 patients (group II) performed both planar and SPET/CT lymphoscintigraphy. SN surgery 
identification percentage, SN anatomical site identification and surgery times were evaluated in each group.  
Results: Group II presented a percentage of SN surgery identification, both globally (96.5%) and in specific sites (axilla 
lymph nodes 94.5%; upon clavicle lymph nodes 100%), better than group I. Furthermore surgery time was shorter in the 
group II (10’-20’). 
Conclusions: SPET/CT allows a more accurate SN identification than planar lymphoscintigraphy, especially in axillar and 
upon-clavicular nodes and contributes to a correct staging of cutaneous MM. It can improve surgery success percentage 
and shortens surgery time, reducing also surgery team irradiation. 
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INTRODUCTION 
Malignant Melanoma (MM) is the most frequent 
malignant cutaneous tumor. The incidence of 
melanoma varies from 3–5/100,000/year in 
Mediterranean countries to 12–25/100,000 in Nordic 
countries. Increased ultraviolet light exposure of a 
genetically predisposed population seems to be, at 
least in part, responsible for an ongoing increase in 
incidence with signs of stabilization of mortality over 
recent decades, except in elderly males [1, 2].  
In the last years, incidence rates are rising 
worldwide with an important increase in many 
European countries, including the Southern and 
Eastern ones [3]. In 2008 the incidence of invasive 
cutaneous MM was globally of almost 200,000 new 
cases with estimated 46,000 deaths for this pathology 
[3]. 
Patients with a histopathologic diagnosis of MM are 
staged by the TNM system that is important to correctly 
assess treatment and prognosis [4, 5].  
Preoperative lymphoscintigraphy and the 
subsequent radio-guided surgery is the most reliable 
methods for the SN detection, contributing to nodal  
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staging by revealing lymphatic drainage patterns and 
the locations of single or multiple SN. The histological 
status of SN is considered to be the most important 
prognostic factor after biopsy of MM. 
In this study we compared planar and SPET/CT 
lymphoscintigraphy in patients with cutaneous MM in 
radio-guided sentinel lymph node surgery identification, 
answering to the following questions: Can SPET/CT 
play a role in the SN research? Furthermore, can 
SPET/CT data modify surgery time?  
MATERIALS AND METHODS 
Patients’ Population 
Our study included 96 patients (58 men and 38 
women) with mean age of 44 years (range 14 - 71 
years) affected by MM. Patients’ characteristics are 
reported in Figure 1. 
The most frequent MM sites in our population were 
trunk (47 patients) and legs (30 patients); head and 
neck were involved in 12 patients and arms in 7 
patients. 
Patients were divided into 2 groups. The group I, of 
66 patients, was submitted to SN research only by 
planar lymphoscintigraphy; the group II, of 30 patients, 
was submitted to SN research by both planar 
lymphoscintigraphy and SPET/CT hybrid technique. 
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In each group we evaluated surgery SN 
identification percentage, the SN anatomical site 
identification and the surgery time.  
NR. TOTAL PATIENTS 
male/female 
96 
58/38 
AGE 
mean (SD) 
range  
 
44 (± 11.55) 
14-71 
AJCC STAGE 
I stage 
II stage 
 
56/96 (58%)  
40/96 (42%) 
CLARK INVASION  
I level 
II level 
III level 
IV and V level 
 
41/96 (43%)  
29/96 (30%) 
26/96 (27%) 
0/96 (0%) 
BRESLOW INVASION (mm) 
Range 
 
0.4-3.1 
ANATOMIC MM SITE 
Head and neck 
Trunk 
Arms 
Legs 
 
12/96 (12.5%) 
47/96 (49%) 
7/96 (7.25%) 
30/96 (31.25%) 
Figure 1: Patients’ characteristics. 
Fisher exact test for percentage comparison was 
used to calculate surgery SN identification percentage; 
T-student test for unpaired samples was performed to 
evaluate the surgery time. A p value <0.05 was 
considered statistically significant. The analyses were 
performed using MedCalc software version 14.12.0 
(MedCalc Software bvba, Ostend, Belgium). 
Technique  
Planar lymphoscintigraphy (all patients): 80 MBq of 
99mTc-Nanocolloid (Nanocoll©, GE Healthcare) were 
injected at the borders of the primary tumor site or 
around the scar. Scintigraphic images were acquired 
with Infinia Hawkeye (GE Healthcare 
Technologies, Milwaukee, WI). Soon after intradermal 
tracer injection a dynamic acquisition was made with 
90 frames in 20”, matrix 128 x 128, LEHR collimators, 
followed by a static acquisition of 300”, matrix 256 x 
256, LEHR collimators. A cutaneous marker was then 
applied at first hot spot of every draining path.  
SPET/CT (only group II patients): SPET exam was 
performed with the following parameters: 360°, 60 
frames x 30”, 128 x 128 matrix, LEHR collimators. We 
used a low dose CT protocol (20mAs, 130Kv, 1.5 pitch, 
Slices 5mm) without contrast media.  
Radio-guided intraoperatory SN research (all 
patients): a 15mm-LVR Gamma-Probe (Scinti-Probe 
MR100 Pol.Hi.Tech.) was passed slowly over the 
drainage path and cutaneous markers.  
Surgery time was calculated from the beginning of 
the incision till the moment of the SN excision. 
The radiation counts were measured on the excised 
SN and on the surgical field to ensure the complete 
removal of the radioactive lymph node. 
RESULTS 
The percentage of SN surgery identification was 
92% in the group I and 96.5% in the group II 
respectively. The SN anatomical site identification 
percentage was 92% for neck lymph nodes and 100% 
for inguinal ones in both groups, while 90% for axilla 
lymph nodes in the group I versus 94.5% in the group II 
and 50% for upon-clavicle lymph nodes in the group I 
versus 100% in the group II. By using Fisher exact test 
for percentage comparison, the difference between the 
two groups was not statistically significant, neither for 
SN surgery identification in overall sites or in specific 
anatomical sites (Figure 2). 
The measured range of the SN surgery time was 
10-38 minutes in the group I and 10-20 minutes in the 
group II (Figure 2). By using T-student test for unpaired 
samples, the difference between the two groups was 
statistically significant (t= -2.485; p=0.015). 
 GROUP I GROUP II p (<0.05) 
SN SURGERY IDENTIFICATION 
Overall sites 92% 96.5% 0.662 
ANATOMICAL SITE SN IDENTIFICATION PERCENTAGES 
Inguinal lymph nodes 100% 100% 1 
Neck lymph nodes 92% 92% 1 
Axillar lymph nodes 90% 94.5% 1 
Upon-clavicle lymph nodes 50% 100% 0.464 
SURGERY TIME 10’-38’ 10’-20’ 0.015 
Figure 2: Results in the two groups. 
DISCUSSION 
Regional lymph nodes are the most common initial 
localization of metastasis in cutaneous MM. SN is the 
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first lymph node involved by the direct lymphatic 
drainage of the tumor. The absence of metastatic 
involvement of this lymph node can almost definitively 
exclude the involvement of the remainder of the 
lymphatic chain, making radical lymphadenectomy 
unnecessary [6]. 
For this reason, the evaluation of lymph nodes 
involvement is essential in patients with MM and, in 
particular, selective SN biopsy results crucial [7]. 
Lymphoscintigraphy shows where lymph from the 
primary tumor site travels and is, therefore, an es-
sential element of lymphatic mapping [4]. It can 
contribute to nodal staging by revealing lymphatic 
drainage patterns and the locations of single or multiple 
sentinel lymph nodes in one or more sites [8]. Selective 
SN biopsy allows also the identification of microscopic 
metastasis, providing more precise staging and more 
adequate treatment [9]. 
Moreover, the histological status of SN is the most 
important prognostic factor after biopsy of MM [4]. 
Multicenter studies demonstrated that recurrences and 
global survival are related to the state of the SN [6].  
Lymphoscintigraphy is of particularly usefulness in 
regions like trunk or head and neck, in which SN 
drainage of melanoma can be variable [10]. 
While preoperative planar lymphoscintigraphy in 
melanoma patients has become a gold standard, the 
role of SPET/CT as part of the standard sentinel 
scintigraphy protocol has yet to be determined [11]. 
Our study focused on comparing planar 
lymphoscintigraphy and SPET/CT technique in patients 
with cutaneous MM, to define if there is a role for 
SPET/CT in radio-guided SN surgery identification and 
if it can modify surgery time. 
SPET/CT was introduced in lymphatic mapping with 
the goal to show more SNs and to show them more 
clearly than conventional lymphoscintigraphy: the 
number and size of the nodes, but also the relationship 
between the SN and its surrounding structures [12]. 
SPET/CT is a multimodal imaging technique that 
fuses the radioactivity distribution detected by SPET 
with the anatomic information gathered by CT. 
SPET/CT has some important advantages over 
conventional lymphoscintigraphy. The tomographic 
acquisition, together with the CT correction for tissue 
attenuation and scatter of the gamma ray signals, imply 
a better SN visualization. The identification of the node 
in relation to anatomic structures facilitates 
interpretation and optimally prepares the surgeon for 
the operation [13]. 
Different studies showed that SPET/CT can provide 
supplementary, clinically relevant information in 50% of 
patients as well as visualize additional SN in patients 
with multiple lymphatic drain basins in approximately 
23% of cases. This results in a change of surgical 
approach in up to 35%, with a different incision, an 
incision at another site or an extra incision, 
demonstrating the great advantage of the use of 
SPET/CT [14, 15]. 
Our results showed that the percentage of SN 
surgery identification in the group II was greater than 
the group I (96.5% vs. 92%), without a statistically 
significant difference. According to the literature, we 
highlighted the use of SPET/CT increases the 
possibility of SN detection. A more accurate localization 
was evident especially in some SN anatomical sites 
such as: the axilla, with an identification percentage of 
94.5% in the group II versus 90% in the group I; the 
upon-clavicle lymph nodes, with an identification 
percentage of 100% in the group II versus 50% in the 
group I. On the contrary, the SN anatomical site 
identification percentage was perfectly the same in the 
two groups for inguinal (100%) or neck (92%) lymph 
nodes. Then, it seems the use of SPET/CT didn’t give 
additional information or advantages in these cases. In 
Figure 3 and 4 we reported two exemplar cases of 
group II in which the SNs drainage is showed by both 
planar and SPECT/CT lymphoscintigraphy. 
The combination of SPET/CT and planar imaging 
allows the identification of SN with precise anatomical 
localization, resulting in increased surgeon confidence, 
especially in difficult surgical cases, as well as 
improved preoperative planning and possibly staging 
[16].  
Also in our experience the surgeon was quite 
confident with the SPET/CT images: he asked for the 
vision of the images and discussed it with the nuclear 
physician before every operation to plan and to 
improve the surgical approach. 
All the above-mentioned advantages of SPET/CT 
lead to a surgery time reduction. Covarelli et al. 
compared conventional imaging to only SPET/CT 
imaging and found that the latter shortened the mean 
biopsy time from 31 to 21 minutes [17].  
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Our results concerning the SN surgery time 
highlighted a shorter one in the group II (10-20 
minutes) compared with the group I (10-38 minutes) 
with a statistically significant difference between the 
two groups (t= -2.485; p=0.015). So, for the patients 
submitted to SPET/CT, it is possible to define a 
reduction of SN surgery mean time of about 40%. 
 
Figure 3: Cutaneous malignant melanoma of the back. Detection of left axillar lymph node at (A) planar (anterior, posterior and 
lateral views) and (B) SPET/CT (coronal, sagittal and axial) lymphoscintigraphy. 
 
Figure 4: Cutaneous malignant melanoma of the back. Detection of right axillar and inguinal lymph nodes at (A) planar 
(posterior and anterior views) and (B) SPET/CT (axial and coronal) lymphoscintigraphy. 
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Moreover, the use of SPET/CT in pre-surgery 
phases has positive effects on the surgical team 
exposition to radiations that is already normally limited, 
with a further global reduction of irradiation. 
Skin contamination, nodes close to the injection site 
and overweight patients are three noted planar images 
limitations that can also be overcome with the 
SPET/CT technique [4]. 
One limitation of the SPET/CT technique can be the 
greater irradiation for patients even if the use of low 
dose CT protocol minimizes this effect. 
CONCLUSIONS 
Our results demonstrated that SPET/CT can play a 
role in patients with MM, allowing a more accurate SN 
identification than planar lymphoscintigraphy, 
especially in axillar and upon-clavicular nodes and 
contributes to a correct staging. 
It facilitates surgical exploration, in particular in 
difficult cases, and improves surgery success 
percentage. Using the hybrid technique, surgery times 
are shorter, reducing also surgery team irradiation. 
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